News 2020-07-03
The Launching of Official Website for 2020 Pharmaceutical Crystallization Summit
J-Star Research, a wholly owned subsidiary of Porton Pharma Solution Ltd., engages with Xtalpi and a broad selection of industrial and academic leaders to host the 2020 Pharmaceutical Crystallization Summit on October 7th and 8th, 2020 (Live).
We will take a close look at the ever-expanding toolbox of capabilities needed to meet challenges in API crystallization. The Summit will emphasize the importance of understanding fundamentals and root causes of problems to effectively speed up process and product development.
Considering the impact of the Covid-19 outbreak, this year’s Summit will be held online (live). This provides the advantage of allowing more attendees than a normal face-to-face meeting. The registration for invited attendees starts in June, and the registration for the general public starts on August 7th, 2020. Registration Reminder for public audience will be released through Porton official channels in August.
Warmly welcome our customers and investors to follow us on this Summit in the coming months.
Website:
https://crystallization-summit.jstar-research.com/
LinkedIn:
https://www.linkedin.com/company/center-for-pharma-crystallization-cfpc/
Others
More
News 2026-10-22
Simplifying Synthesis with Radical Cross-Coupling: Prof. Phil S. Baran of Scripps Research Lectures at Porton
The event was hosted by Dr. Yongli Zhong, CSO, and attended by Mr. Oliver Ju, Chairman and CEO; Mr. Yunxing Yin, VP and Head of the Small Molecule Platform, and more than 200 R&D and technical staff.

News 2026-10-16
Porton Achieves Third-Party Verification for Its First Commercial Product LCA and PCF Study
Conducted in accordance with ISO 14040:2006 and ISO 14044:2006 (Life Cycle Assessment) and ISO 14067:2018 (Product Carbon Footprint) standards, the study employs a cradle-to-gate system boundary, marking the formal extension of Porton's ESG management from the organizational level to the product level.